This DoD grant supports developing burn-focused medical devices, drugs, or clinical guidelines for use in resource-limited military environments, translating research into practical products.
Dept. of the Army -- USAMRAA has archived this opportunity.
Funder: Dept. of the Army -- USAMRAA
Due Dates: June 23, 2025 (Pre-Application) | September 8, 2025 (Full Application)
Funding Amounts: Up to $1.7M total costs per award (max 3 years); ~2 awards; total program funding $3.4M
Summary: Supports translation of preclinical burn research into products (devices, drugs, or guidelines) for use in austere, resource-limited military environments.
Key Information: Clinical trials and clinical research are not permitted; proof-of-concept and prototype required at pre-application.
This opportunity, offered by the Department of Defense (DoD) through the U.S. Army Medical Research Acquisition Activity (USAMRAA), funds the development of burn-focused medical products for military use. The goal is to translate promising preclinical findings into tangible products—such as medical devices, drugs, or clinical practice guidelines—that can be applied in austere, resource-limited, distributed operational environments, especially at or near the point of injury.
Projects must address at least one of the FY25 Military Burn Research Program (MBRP) Technology/Therapeutic Development Award (TTDA) focus areas and demonstrate clear military relevance. Both tangible products and knowledge products (if directly supporting a technology or therapeutic) are eligible, provided they are at a minimum Technology Readiness Level (TRL) or Knowledge Readiness Level (KRL) of 3 at pre-application.
Clinical trials and clinical research involving human subjects are not allowed under this mechanism.